NewAmsterdam Pharma CSO Johannes Kastelein disposes of 125,000 shares for USD 3.36 million
NAMS•Share sale and option exercise reported
- NewAmsterdam Pharma Chief Scientific Officer Johannes Jacob Pieter Kastelein reported a 125,000-share sale at a weighted average price of USD 26.91 on Aug. 24.
- The sale followed the exercise of options for 125,000 ordinary shares at an exercise price of EUR 1.16392.
- Indirect ordinary-share holdings fell to 69,302 shares following the transactions.
- Indirect option holdings rose to 395,229 options after the exercise.
